A high platelet count, called thrombocytosis, means your blood contains more than 450,000 platelets per microliter. The normal range is 150,000 to 450,000. In the vast majority of cases, an elevated count is a temporary reaction to something else happening in your body, like an infection, inflammation, or iron deficiency. Less commonly, it signals a problem with the bone marrow itself.
Reactive vs. Primary Thrombocytosis
There are two broad categories, and they differ significantly in what they mean for your health. Reactive (or secondary) thrombocytosis is by far the more common type. Your platelet count rises because your body is responding to another condition. The platelets themselves function normally, and the count typically drops once the underlying trigger is addressed.
Primary thrombocytosis, also called essential thrombocythemia, is a bone marrow disorder where the marrow produces too many platelets on its own. This is driven by genetic mutations in the bone marrow cells. The most common is a mutation called JAK2, found in roughly 54% to 66% of patients. A second mutation, CALR, appears in 15% to 24% of cases, while a third, MPL, is rare at under 4%. Primary thrombocytosis is far less common than reactive causes but requires ongoing monitoring and sometimes treatment.
The Most Common Triggers
Doctors sometimes use the shorthand “5 I’s” to remember the usual reactive causes: infection, inflammation, iron deficiency, ischemia (reduced blood flow to tissues), and infarction (tissue damage from blocked blood supply). Here’s how each works.
Infection is the single most frequent trigger, especially in children, where it accounts for about 75% of reactive cases. Bacterial, viral, and chronic infections like tuberculosis can all raise platelet counts. The mechanism involves an inflammatory signaling molecule called IL-6, which ramps up platelet production in the bone marrow.
Chronic inflammation from conditions like rheumatoid arthritis, inflammatory bowel disease, and sarcoidosis drives the same IL-6 pathway, keeping platelet counts elevated for as long as the inflammation persists.
Iron deficiency is a surprisingly common cause. Even without obvious symptoms of anemia, low iron stores can push platelet production higher. The exact mechanism isn’t fully understood, but elevated levels of erythropoietin (a hormone your body makes when it’s low on red blood cells) appear to play a role.
Surgery and blood loss can also cause a temporary spike. Up to 90% of people who have their spleen removed develop thrombocytosis afterward, because the spleen normally filters out and stores about a third of your circulating platelets. Without it, all those platelets stay in the bloodstream. Even a functionally underactive spleen can produce the same effect.
When High Platelets Point to Cancer
An elevated platelet count can occasionally be a sign of an underlying cancer, even before other symptoms appear. Tumors in several organs overproduce IL-6 as a growth signal, which stimulates platelet production as a side effect. The cancers most associated with this paraneoplastic thrombocytosis include lung, ovarian, colorectal, gastric, renal, and breast cancers.
The prevalence varies by cancer type. In studies of lung cancer patients, 16% to 32% had elevated platelets at diagnosis. In mesothelioma, the rate was nearly 55%. For breast cancer it was lower, around 4%, but still carried a measurably worse prognosis. Across gynecologic cancers, a meta-analysis of nearly 3,500 patients found about 20% had high platelet counts at diagnosis, and those patients had a 62% higher risk of death compared to those with normal counts.
This doesn’t mean a high platelet count equals cancer. It means that when counts are elevated and no obvious reactive cause is found, your doctor will likely investigate further.
Symptoms You Might Notice
If your platelet count is only mildly elevated, you probably won’t feel anything at all. Many people discover it incidentally through routine bloodwork. Symptoms tend to appear when counts climb significantly higher or when an underlying bone marrow disorder causes the platelets to function abnormally.
When symptoms do occur, they’re mostly related to blood clots forming in places they shouldn’t. These can include headaches, dizziness, vision changes, chest pain, shortness of breath, weakness or numbness on one side of the body, and pain or swelling in a leg. Paradoxically, very high platelet counts can also cause unusual bleeding, such as nosebleeds, bleeding gums, or blood in urine or stool, because the excess platelets can deplete clotting factors or function poorly.
The Risk of Blood Clots
For reactive thrombocytosis, the clotting risk is generally low because the platelets work normally. The real concern is with primary bone marrow disorders like essential thrombocythemia and polycythemia vera.
A large study of over 124,000 Medicare patients with essential thrombocythemia found that about 24.5% experienced a blood clot during follow-up. Among those with polycythemia vera, the rate was 28.4%. The most common event in both groups was ischemic stroke, accounting for 42% to 46% of all clotting episodes. Patients who developed a clot within the first year of diagnosis had significantly shorter survival: a median of 3.7 years for essential thrombocythemia compared to 6.7 years for those who remained clot-free.
How Doctors Figure Out the Cause
The first step is confirming the count is genuinely elevated. Automated blood counters can sometimes mistake other particles in the blood for platelets, producing a falsely high number. A peripheral blood smear, where a technician examines a drop of blood under a microscope, is a simple way to verify the result.
From there, doctors look for reactive causes first, since these are far more common. Markers of inflammation like C-reactive protein (CRP), ferritin, and erythrocyte sedimentation rate (ESR) are typically elevated in reactive thrombocytosis but normal in bone marrow disorders. IL-6 levels follow the same pattern. Iron studies can reveal deficiency. A review of recent infections, surgeries, or chronic conditions often points to the trigger.
If no reactive cause is apparent, testing shifts toward the bone marrow. Genetic testing for JAK2, CALR, and MPL mutations can identify primary thrombocytosis. The current diagnostic threshold set by the World Health Organization for essential thrombocythemia is a sustained platelet count above 450,000, combined with specific bone marrow biopsy findings and the presence of one of these mutations.
How High Platelets Are Managed
For reactive thrombocytosis, treatment focuses on the underlying cause. Treat the infection, correct the iron deficiency, or manage the inflammatory condition, and platelet counts typically return to normal on their own. No specific platelet-lowering therapy is needed.
For primary thrombocytosis, management depends on your risk of clotting. Patients classified as very low risk with no symptoms may not need treatment at all, even if their counts are quite high. Low-risk patients are often placed on low-dose aspirin, sometimes twice daily rather than once, particularly if they have cardiovascular risk factors. For high-risk patients, those with a history of blood clots or who are over 60, the standard approach combines a medication that reduces platelet production with aspirin therapy. Patients with a history of venous clots may also need long-term blood thinners.
The goal isn’t necessarily to bring the platelet count to a specific number. It’s to reduce clotting risk and resolve any symptoms. Some patients with essential thrombocythemia live for decades with careful monitoring and minimal intervention.